CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for YSB Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

YSB Inc
Yaoshibang Building
No. 8 Brand Street, TIT Creative Industr
GUANGZHOU, GNG  China Ticker: 98859885

Business Summary
YSB Inc is an investment holding company mainly engaged in providing wholesale and retail of medicines and health care products as well as platform business services. The Company's businesses mainly include the wholesale of pharmaceuticals and health care products through offline or online platforms, conducting retail sales of pharmaceuticals and health care products through its retail stores, operates online platforms, provideing software-as-a-service (SaaS) solutions to downstream pharmacies, and offering medical testing services to primary medical institutions. The Company mainly conducts businesses in the domestic market.
(Source: ARS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202512/31/2024Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board, Chief Executive Officer BuzhenZhang 48 4/15/2022 1/1/2015
Chief Financial Officer, Executive Director, Joint Company Secretary FeiChen 39 5/14/2022 4/15/2022
Vice President HaodongXiao 59 12/1/2018 12/1/2018
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 6,620 (As of 6/30/2025)
Outstanding Shares: 640,485,502 (As of 6/30/2024)
Stock Exchange: HKG


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 7, 2025